This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n12	http://dx.doi.org/10.1210/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q34835217

rdf:type

wikibase:Item

schema:description

מאמר מדעי 2008年論文 2008年论文 ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vědecký článek artículu científicu espublizáu en 2008 мақолаи илмӣ bilimsel makale 2008 nî lūn-bûn 2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված vitenskapelig artikkel 2008년 논문 wissenschaftlicher Artikel 2008年論文 artikulong pang-agham articol științific videnskabelig artikel (udgivet 2008) επιστημονικό άρθρο naučni članak 2008年论文 artigo científico (publicado na 2008) научная статья наукова стаття, опублікована у вересні 2008 vetenskaplig artikel 2008年の論文 2008年论文 scientific article article scientific vitskapeleg artikkel 2008年论文 مقالة علمية article scientifique (publié 2008) artykuł naukowy научни чланак 2008年論文 artikull shkencor article científic บทความทางวิทยาศาสตร์ wetenschappelijk artikel mokslinis straipsnis мақолаи илмӣ 2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած artículo científico publicado en 2008 2008年论文 научна статия articolo scientifico artigo científico مقالهٔ علمی სამეცნიერო სტატია tudományos cikk teaduslik artikkel tieteellinen artikkeli 2008年論文 научни чланак scienca artikolo 2008年论文 2008年論文 bài báo khoa học vedecký článok artigo científico (publicado na 2008) سائنسی مضمون

p:P577

wds:Q34835217-DA216B52-32FD-4EEB-B3EA-EAB842F3B98F

wdt:P577

2008-09-23T00:00:00Z

p:P407

wds:Q34835217-4CE635DD-BAF6-4613-90F2-C2102C053761

wdt:P407

wd:Q1860

p:P2093

wds:Q34835217-3053E1CE-B3EF-4F71-8962-7486B6B9CC43 wds:Q34835217-32A208BB-52F3-4729-B6F1-68BE34E0118B wds:Q34835217-6CEB6029-E261-4800-BC7E-D20F9C6DE5DA wds:Q34835217-4D7F8207-070E-414A-8A76-1DD4018D15BC wds:Q34835217-10971ECA-6202-439B-9F91-48317F87FF9B wds:Q34835217-F691D2B2-738D-44F1-BAB3-8D6DF15C2F36 wds:Q34835217-FDB77BA8-4718-4759-B09D-918D72A883D4 wds:Q34835217-8A289B22-B8C9-4C46-B673-7410070E15EA wds:Q34835217-95C5AEEB-27D6-49E9-8E3E-9942CD927B5F

wdt:P2093

Albiglutide Study Group Murray W Stewart Rebecca J Hodge Jessica E Matthews Robert L Dobbins M Claire Holland Mark A Bush Susan E Walker Erika H De Boever

rdfs:label

Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes

skos:prefLabel

Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes

schema:name

Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes

p:P1476

wds:Q34835217-64B2BFA7-7CF2-45AA-B680-745B45E253BD

wdt:P1476

Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes

p:P304

wds:Q34835217-77A61663-4039-4866-B44D-A108B9BA05CE

wdt:P304

4810-4817

p:P31

wds:Q34835217-406846CF-D9CB-4236-8994-24CC3761DDAF

wdt:P31

wd:Q13442814

p:P921

wds:Q34835217-4F28AFB4-2E37-48DB-ADEC-F27F59AAF08B wds:Q34835217-B8139897-09F8-499A-92BF-DC30D0E19B03 wds:Q34835217-E2E21526-8547-4474-A53B-CA852AF28A50

wdt:P921

wd:Q181600 wd:Q3025883 wd:Q323936

p:P698

wds:Q34835217-2C945DA4-0B35-4C80-9DA4-E72715262A3D

wdtn:P698

n11:18812476

wdt:P698

18812476

p:P1433

wds:Q34835217-C7BBCA8E-144E-410C-A8B6-886EF97BDA1F

wdt:P1433

wd:Q3186902

p:P433

wds:Q34835217-D8F201C2-60F6-4766-8058-04A532D057FF

p:P478

wds:Q34835217-78284DDE-DC42-4E09-9BFC-27BA06390FDF

wdt:P433

12

wdt:P478

93

p:P356

wds:Q34835217-C7941523-246D-4C8D-8314-C320B5D8F648

wdtn:P356

n12:JC.2008-1518

wdt:P356

10.1210/JC.2008-1518

p:P5875

wds:Q34835217-A1182C40-7A85-4BEA-BFAE-2C47F5719533

wdt:P5875

23277508